Status: Recruiting
ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS)
Active surveillance study using real-world data collected in the ASSURE Patient Registry. Outcome measures are based on analysis of ASSURE Registry data including data recorded by the WCD then annotated by clinical experts in electrophysiology.
Participants needed: 5,179
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Kestra Medical Technologies, Inc.Updated: Sep 2, 2025Locations: 1Duration: 3 Months
Eligibility criteria
Adult patient prescribed the ASSURE wearable cardioverter defibrillator [+1]
Patients who do not meet the Inclusion criteria